| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,450 |
7,447 |
$592K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,801 |
2,305 |
$120K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,258 |
880 |
$119K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,988 |
936 |
$24K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
627 |
579 |
$18K |
| 80053 |
Comprehensive metabolic panel |
1,979 |
1,717 |
$17K |
| 85027 |
|
2,518 |
2,139 |
$9K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
255 |
139 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
399 |
369 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
114 |
110 |
$5K |
| 83735 |
|
648 |
557 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
186 |
168 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
54 |
31 |
$1K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
17 |
14 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
717 |
644 |
$756.26 |
| 81003 |
|
355 |
313 |
$700.21 |
| 84443 |
Thyroid stimulating hormone (TSH) |
34 |
28 |
$646.07 |
| 82553 |
|
54 |
44 |
$583.70 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
87 |
82 |
$573.50 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
60 |
54 |
$516.20 |
| 71046 |
Radiologic examination, chest; 2 views |
75 |
71 |
$476.97 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
16 |
12 |
$422.46 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
326 |
292 |
$415.85 |
| 84484 |
|
68 |
50 |
$414.96 |
| 81025 |
|
101 |
87 |
$384.73 |
| 80306 |
|
29 |
24 |
$370.48 |
| 81001 |
|
84 |
75 |
$360.96 |
| 86328 |
|
12 |
12 |
$348.26 |
| 87186 |
|
25 |
24 |
$200.25 |
| 83880 |
|
14 |
12 |
$195.72 |
| 87077 |
|
25 |
24 |
$187.04 |
| 71045 |
Radiologic examination, chest; single view |
50 |
45 |
$174.80 |
| 87807 |
|
13 |
13 |
$163.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
376 |
348 |
$159.60 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
22 |
14 |
$96.00 |
| 36415 |
Collection of venous blood by venipuncture |
1,004 |
888 |
$2.24 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
89 |
86 |
$0.00 |